Schizophrenia risk from complex variation of complement component 4
By Aswin Sekar, Allison R. Bialas, Heather de Rivera, Avery Davis, Timothy R. Hammond, Nolan Kamitaki, Katherine Tooley, J. Presumey, M. Baum, Vanessa E. Van Doren and 7 more. Nature, 2016
2,241 citations recorded by the source corpus.
Schizophrenia is a heritable brain illness with unknown pathogenic mechanisms. Schizophrenia’s strongest genetic association at a population level involves variation in the major histocompatibility complex (MHC) locus, but the genes and molecular mechanisms accounting for this have been challenging to identify. Here we show that this association arises in part from many structurally diverse alleles of the complement component 4 (C4) genes. We found that these alleles generated widely varying levels of C4A and C4B expression in the brain, with each common C4 allele associating with schizophrenia in proportion to its tendency to generate greater expression of C4A. Human C4 protein localized to neuronal synapses, dendrites, axons, and cell bodies. In mice, C4 mediated synapse elimination during postnatal development. These results implicate excessive complement activity in the development of schizophrenia and may help explain the reduced numbers of synapses in the brains of individuals with schizophrenia.
Subfields: Biological Psychiatry, Immunology, Neurology
View Paper: https://www.semanticscholar.org/paper/a2b9e68ffc292a46093768a320acb3873c3783db
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biological Psychiatry
In Neurology
Citations in the corpus
- An expanded view of complex traits: from polygenic to omnigenic (2017, background): “…interpretable roles in disease, such as the roles of IRX3 and IRX5 in controlling adipocyte differentiation, with consequent effects on obesity (Claussnitzer et al., 2015), or the role of the C4 genes on synaptic pruning in development, thereby affecting schizophrenia risk (Sekar et al., 2016).”
- Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment (2023, background): “While attempts have been made to characterise the effects of specific alleles [90], most contribute only a minimal degree of risk (median odds ratio 1.”